Analyze This: New Book Examines Shrinks On Screen

March 30, 1999

The familiar Hollywood theme of psychiatrists and psychiatric treatment takes a turn "on the couch" in a new book by Glen Gabbard, M.D. and Krin Gabbard, Ph.D. Psychiatry and the Cinema, by published by the American Psychiatric Publishing Group, is a careful scrutiny of cinematic psychiatrist past and present. Through an examination of physician and treatment caricatures, the authors illustrate how moviegoers are led to perceive, and frequently misperceive, the practice of psychiatry and mental illness.

"If psychiatry had not existed, the movies would have had to invent it -- and in a sense they did," writes Irving Schneider, M.D. in the book's foreword. "Psychiatry and the Cinema tells the story of how the movie industry took the profession of psychiatry and transformed it into a hybrid that joined the fantasies of the public with its own quest for profit."

Glen Gabbard, M.D. is a professor in the Karl Menninger School at the Menninger Clinic and the University of Kansas School of Medicine in Wichita, KS. Krin Gabbard, Ph.D. teaches film, literature, and cultural studies at the State University of New York at Stony Brook.

To order a copy of Psychiatry and the Cinema call 1-800-368-5777.
-end-
Additional Contact:
Melissa Saunders Katz
202-682-6142 or mkatz@psych.org

The American Psychiatric Association is a national medical specialty society, founded in 1844, whose 40,000 physician members specialize in the diagnosis and treatment of mental and emotional illnesses and substance use disorders.



American Psychiatric Association

Related Psychiatry Articles from Brightsurf:

The Lancet Psychiatry: First UK-wide study describes brain complications in some patients with severe COVID-19
A study of 153 patients treated in UK hospitals during the acute phase of the COVID-19 pandemic describes a range of neurological and psychiatric complications that may be linked to the disease and is published today in The Lancet Psychiatry journal.

Revisiting the potential of using psychedelic drugs in psychiatry
Before they were banned about a half century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders.

Psychiatry: Five clearly defined patterns
Psychiatrists led by Nikolaos Koutsouleris from Ludwig-Maximilians-Universitaet (LMU) in Munich have used a computer-based approach to assign psychotic patients diagnosed as bipolar or schizophrenic to five different subgroups.

The Lancet Psychiatry: Life-course-persistent antisocial behaviour may be associated with differences in brain structure
Individuals who exhibit life-course-persistent antisocial behaviour - for example, stealing, aggression and violence, bullying, lying, or repeated failure to take care of work or school responsibilities - may have thinner cortex and smaller surface area in regions of the brain previously implicated in studies of antisocial behaviour more broadly, compared to individuals without antisocial behaviour, according to an observational study of 672 participants published in The Lancet Psychiatry journal.

The Lancet Psychiatry: Abortion does not increase a woman's risk of attempting suicide
Policies based on the notion that undergoing an abortion causes or increases women's risk of suicide attempts are misinformed, according to the results of a 17-year-long observational study including more than half a million 18 to 36-year-old Danish women who had a first, first-trimester abortion, published in The Lancet Psychiatry journal.

How artificial intelligence can transform psychiatry
Scientists have developed a new mobile app that categorizes mental health status based on speech patterns.

The Lancet Psychiatry: Improved support after self-harm needed to reduce suicide risk
To reduce the high risk of suicide after hospital attendance for self-harm, improved clinical management is needed for all patients - including comprehensive assessment of the patients' mental state, needs, and risks, as well as implementation of risk reduction strategies, including safety planning.

The Lancet Psychiatry: Insufficient evidence that medicinal cannabinoids improve mental health
The most comprehensive analysis of medicinal cannabinoids and their impact on six mental health disorders -- combining 83 studies including 3,000 people -- suggests that the use of cannabinoids for mental health conditions cannot be justified based on the current evidence.

'Spin' found in over half of clinical trial abstracts published in top psychiatry journals
'Spin' -- exaggerating the clinical significance of a particular treatment without the statistics to back it up -- is apparent in more than half of clinical trial abstracts published in top psychology and psychiatry journals, finds a review of relevant research in BMJ Evidence Based Medicine.

The Lancet Psychiatry: Compensatory strategies to disguise autism spectrum disorder may delay diagnosis
For the first time, compensatory strategies used by people with autism have been investigated and collated in a qualitative study using an online survey of 136 adults, published in The Lancet Psychiatry journal.

Read More: Psychiatry News and Psychiatry Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.